Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 253
Filtrar
1.
J Exp Med ; 140(2): 494-507, 1974 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-4858717

RESUMO

Cell line LA-49, derived from pleural fluid cells of a patient with IgD multiple myeloma, was established in culture and maintained for more than 1 yr. The D-myeloma protein produced in culture was similar to the serum D-myeloma protein in electrophoretic mobility and in delta- and lambda-chain antigens. The plasma cell tumor culture, LA-49, differed from numerous immunoglobulin-producing B-lymphoblastoid cell lines established in this laboratory in: (a) Morphology (revealing various stages of maturation); (b) type of immunoglobulin produced (IgD vs. IgM, IgG, and/or, rarely, IgA); (c) growth characteristics (requirement of plasmacyte-stimulating factor); and (d) chromosomal features (polyploid vs. pseudodiploid). A growth factor was needed for cell division and maintenance of culture viability. This factor was supplied readily by irradiated feeder layers of normal human fibroblasts or conditional media from fibroblast cultures. Preliminary characterization of this factor revealed it to be a protein with a mol wt of approximately 150,000 daltons.


Assuntos
Proteínas Sanguíneas/isolamento & purificação , Linhagem Celular/imunologia , Imunoglobulina D , Mieloma Múltiplo/imunologia , Plasmócitos/imunologia , Animais , Bovinos , Divisão Celular/efeitos dos fármacos , Cromossomos/análise , Radioisótopos de Cobalto , Meios de Cultura , Técnicas de Cultura , Feminino , Fibroblastos/imunologia , Fibroblastos/efeitos da radiação , Humanos , Imunoglobulina A/análise , Fragmentos de Imunoglobulinas , Imunoglobulina G/análise , Imunoglobulina M/análise , Microscopia Eletrônica , Pessoa de Meia-Idade , Proteínas de Neoplasias/análise , Plasmócitos/efeitos dos fármacos , Efeitos da Radiação , Estimulação Química
2.
Science ; 156(3777): 947-8, 1967 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-4164622

RESUMO

Two antigenic subtypes of human lambda polypeptide chains were distinguished by rabbit antiserum produced to a lambda Bence Jones protein. Lambda Bence Jones proteins and G myeloma proteins with lambda light chains were identified as being in one or the other subtype. The Oz (+) lambda chain subtype is present in light chains from pooled normal human immunoglobulin G and in whole normal immunoglobulin G molecules.


Assuntos
Proteína de Bence Jones , Peptídeos/análise , gama-Globulinas/análise , Animais , Humanos , Soros Imunes , Imunodifusão , Coelhos
3.
Science ; 164(3887): 1524-5, 1969 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-4182344

RESUMO

In synchronized human lymphoid cell lines, production of immunoglobulins G and M is greatest during the late Gl and S phases of the cell cycle. Little immunoglobulin appears immediately before, during, and immediately after mitosis. The results indicate that transcription of immunoglobulin genes takes place during a limited part of the mitotic cycle.


Assuntos
Linfoma de Burkitt/imunologia , Código Genético , Linfócitos/metabolismo , Mitose , Esferocitose Hereditária/imunologia , gama-Globulinas/biossíntese , Linhagem Celular , Humanos , Imunoglobulina G/biossíntese , Imunoglobulina M/biossíntese , Linfócitos/imunologia , Baço/patologia
4.
Science ; 163(3874): 1460-2, 1969 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-5773111

RESUMO

Soluble preparations of HL-A alloantigens were separated by gel filtration into components having either the "LA" series or the "4" series of alloantigenic determinants. This separation may indicate that several different structural cistrons within the HL-A (locus) control the expression of these two series of determinants. The alternative possibility, in which one structural cistron with multiple mutational sites controls the synthesis of a single molecule cannot be excluded.


Assuntos
Membrana Celular/imunologia , Isoantígenos/isolamento & purificação , Tecido Linfoide/imunologia , Baço/imunologia , Antígenos de Grupos Sanguíneos , Cromatografia em Gel , Técnicas de Cultura , Histocompatibilidade , Humanos , Imunoglobulina G , Tecido Linfoide/citologia , Mutação , Papaína , Baço/citologia
5.
Science ; 152(3726): 1259-61, 1966 May 27.
Artigo em Inglês | MEDLINE | ID: mdl-5937117

RESUMO

Several lines of human lymphoid cells derived from malignant lym phoma produce immunoglobulins in vitro. Immunoglobulins G(I(g)G, (gamma)G) are synthesized in two cell lines and immuno-lobulin M (I(g)M, (gamma)M) in one.


Assuntos
Formação de Anticorpos , Técnicas de Cultura , Linfoma/imunologia , Neoplasias/imunologia , Humanos , Imunoeletroforese
6.
Natl Med J India ; 22(5): 257-60, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20334050

RESUMO

BACKGROUND: Clinicians and associated health professionals charged with prescribing antiretroviral therapy (ART) deal with continuously evolving new drugs and combinations. To meet the needs of clinicians in India for ongoing education in this field, continuing medical education (CME) programmes on ART for HIV/AIDS were developed, conducted, evaluated and revised. Over a 2-year period, 2005-2007, 3 CME programmes for ART were conducted for physicians and a fourth (predominantly) for paediatricians. METHODS: Both 1- and 2-day CME programmes on various aspects of ART were held on weekends for professionals treating patients with AIDS in Delhi and adjacent states. Topics included characteristics of ART drugs, their dosages, monitoring and toxicity management, adherence, complications of therapy, dealing with treatment failure and HIV co-infections. These topics were addressed in lectures and group discussions and via case presentations. Programmes were evaluated by anonymous response to questionnaires, by a 1-year follow up of participants and by informal discussions with participants and faculty. Detailed analyses and a recommended format for these programmes are presented. RESULTS: The CMEs were attended primarily by clinicians (physicians and paediatricians). Nurses, laboratory scientists, and others involved in the treatment of AIDS also attended the programmes. An interactive workshop format was evolved with substantial time devoted to discussions and case analyses. One-day programmes such as the one included here can be comprehensive and effective. The educational needs of healthcare professionals who provide care and support to patients receiving ART were similar to those of the prescribing doctors. Because of new drugs being made available and with continued clinical experience, updated programme content was required each year. Participants preferred case-based interactive discussions rather than didactic lectures. Participants suggested that there should be more time for discussion after each talk. CONCLUSION: Annual CME programmes focused on ART are required to meet the professional needs of clinicians in India for providing quality care management to patients with AIDS.


Assuntos
Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Pessoal Técnico de Saúde , Educação Médica Continuada , Avaliação das Necessidades , Feminino , Humanos , Masculino
7.
J Clin Invest ; 48(4): 785-93, 1969 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-4180120

RESUMO

A new heavy chain disease protein ((gamma)HCD-JM) has been characterized by antigenic and structural criteria. The protein belongs to the IgG3-subclass and is closely related to Fc-fragment of G3-immunoglobulins. The predominant N-terminal amino acid of this protein is glutamic acid in the uncyclized form, and that of another (gamma)HCD is glycine. Studies of the N-terminal peptides indicate that the N-terminal portion of the (gamma)3-heavy polypeptide chain is absent from the (gamma)HCD-JM. These findings rule out a process of normal heavy chain initiation and a large deletion of the Fd region as being responsible for these two heavy chain disease proteins. The (gamma)HCD-JM is a secretory product of cells from bone marrow as shown by studies of in vitro incorporation of amino acids-(14)C. Bone marrow and lymph node have a population of lymphoplasmacytic cells which by immunofluorescence contain (gamma)-heavy chain antigens in the absence of light chain antigens.


Assuntos
Proteínas Sanguíneas/biossíntese , Doença das Cadeias Pesadas/sangue , gama-Globulinas/biossíntese , Aminoácidos/análise , Proteínas Sanguíneas/análise , Medula Óssea/análise , Células da Medula Óssea , Isótopos de Carbono , Imunofluorescência , Humanos , Imunoeletroforese , Ultracentrifugação , gama-Globulinas/análise
8.
J Natl Cancer Inst ; 61(2): 301-6, 1978 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-355647

RESUMO

Cellular immune functions were studied in patients with early bladder cancer 2 hours after ingestion of either levamisole or a placebo. Random monocyte motility was significantly increased (P less than 0.025) in 13 of 17 patients receiving levamisole. Monocyte chemotaxis was significantly increased (P less than 0.025) in 16 of the 17 patients. Random monocyte motility and monocyte chemotaxis did not change in either 8 patients on the placebo or in 15 normal controls. Monocytes from normal donors showed increased random motility and chemotaxis after incubation with levamisole in vitro. These results indicated that increases in peripheral blood monocyte motility followed oral administration of levamisole. Kinetic studies indicated that these effects were rapid in onset and short lived.


Assuntos
Carcinoma de Células de Transição/tratamento farmacológico , Quimiotaxia de Leucócito/efeitos dos fármacos , Levamisol/farmacologia , Monócitos/efeitos dos fármacos , Neoplasias da Bexiga Urinária/tratamento farmacológico , Administração Oral , Adulto , Idoso , Carcinoma de Células de Transição/imunologia , Movimento Celular/efeitos dos fármacos , Ensaios Clínicos como Assunto , Feminino , Humanos , Lectinas/farmacologia , Levamisol/administração & dosagem , Ativação Linfocitária/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Monócitos/imunologia , Neoplasias da Bexiga Urinária/imunologia
9.
Cancer Res ; 36(4): 1492-8, 1976 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1083290

RESUMO

Two characteristics of immune responses to weakly immunogenic plasma cell tumors were demonstrated in this study. (a) Elevated lymphoproliferative responses following in vivo inoculation of sublethal doses of plasma cell tumors were detected by a mixed lymphocyte-tumor interaction (MLTI) assay. Specificity of elevated MLTI responses correlated with resistance to in vivo tumor challenge. These responses were dependent upon the presence of thymus-derived cells. (b) Spleen and lymph node cells showed markedly different patterns of MLTI activity following plasma cell tumor immunization. Spleen cell responses were depressed for the first 30 days postimmunization, whereas lymph node cells showed augmented MLTI reactivity immediately after immunization. These observations indicated that lymphocyte populations from different lymphoid organs may show widely dissimilar responses in vitro at the same point in the in vivo development of tumor resistance.


Assuntos
Imunização , Ativação Linfocitária , Plasmocitoma/imunologia , Animais , Soro Antilinfocitário/farmacologia , Linhagem Celular , Feminino , Linfonodos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Mitomicinas/farmacologia , Transplante de Neoplasias , Neoplasias Experimentais/imunologia , Baço/imunologia , Linfócitos T/imunologia , Transplante Isogênico
10.
Cancer Res ; 37(8 Pt 2): 2875-8, 1977 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-872117

RESUMO

Delayed cutaneous hypersensitivity tests, especially skin tests with dinitrochlorobenzene, are impaired increasingly as the amount of tumor increases. Recall antigens are less sensitive indicators of disease. Therapy, especially radiotherapy, also depresses cell-mediated immunity. Removal of tumor, however, allows these tests to return to normal. Dinitrochlorobenzene skin testing can contribute significantly to prognostic evaluation. An important facet of the tumor-host relationship is measured, and this reflects factors that are independent of tumor staging. Combination of tumor staging and dinitrochlorobenzene-delayed hypersensitivity testing can provide a strong indication of the clinical course, especially for the year following initial treatment of invasive or metastatic transitional cell carcinoma of the bladder.


Assuntos
Carcinoma de Células de Transição/imunologia , Imunidade , Neoplasias da Bexiga Urinária/imunologia , Antígenos , Carcinoma de Células de Transição/patologia , Carcinoma de Células de Transição/radioterapia , Dinitroclorobenzeno , Humanos , Hipersensibilidade Tardia , Imunidade/efeitos da radiação , Imunidade Celular , Prognóstico , Testes Cutâneos , Neoplasias da Bexiga Urinária/patologia , Neoplasias da Bexiga Urinária/radioterapia
11.
Cancer Res ; 35(10): 2693-8, 1975 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1057451

RESUMO

Lymphocyte-dependent antibodies (LDA's) directed against antigenic determinants present on lymphoblastoid cell lines as well as human leukemia blast cells were demonstrated in heterologous antisera obtained by immunizing rabbits with a membrane fraction from RPMI-4265 (a lymphoblastoid cell line derived from a patient with chronic myelogenous leukemia). LDA was present at high titers against B-lymphoblastoid, myelomonocytic, and stem cell lines. The T-lymphoblastoid cell line MOLT-4, however, did not react. LDA was demonstrated against acute myelogenous as well as lymphoblastic leukemia cells. The reactivity was not directed against phytohemagglutinin-induced blastoid antigens, fetal antigens, or fetal calf serum. Absorptions with lymphoblastoid cell lines removed all LDA reactivity. Similar results were obtained by absorbing the rabbit antiserum with acute lymphoblastic and/or acute myelogeneous leukemia cells. These findings indicate the presence of cross-reactive antigens between lymphoblastoid cell lines and leukemia cells. Furthermore, cross-reactivity between acute lymphoblastic and acute myelogenous leukemia cells was demonstrated.


Assuntos
Anticorpos Antineoplásicos , Antígenos de Neoplasias/análise , Reações Cruzadas , Leucemia Linfoide/imunologia , Linfócitos/imunologia , Absorção , Animais , Linhagem Celular , Membrana Celular/imunologia , Feto/imunologia , Humanos , Lectinas , Leucemia Mieloide Aguda/imunologia , Coelhos/imunologia
12.
Cancer Res ; 41(11 Pt 1): 4324-30, 1981 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6458353

RESUMO

Depressed T-lymphocyte function as assessed by delayed-type hypersensitivity reactions and in vitro proliferative response to mitogens is a characteristic finding in many types of solid tumors, including bladder carcinoma. Peripheral blood leukocytes from 16 patients with transitional cell carcinoma of the bladder were compared with age-matched, control subjects. Both the unfractionated leukocytes containing 10 to 30% monocytes and the lymphocyte-enriched preparations, obtained by monocyte depletion with iron filing ingestion, were analyzed. Mixed leukocyte culture-induced cytotoxicity was depressed in the patient group; the amount of depression was directly correlated to the extent of the disease. In patients who underwent surgical removal of tumor, the mixed leukocyte culture-induced cytotoxicity appeared normal. This mixed leukocyte culture-generated cytotoxic response was a more sensitive indicator of tumor effect than was the induced proliferative response. Removal of phagocytic or adherent monocytes from the responding cell population caused a significant increase in the generated cytotoxicity, especially in those patients with invasive disease. These suppressive effects could be partially reconstituted by quantitative addition of the separated monocytes back to the responding lymphocyte culture. The depressed lymphocyte-mediated cytotoxicity present in these bladder cancer patients was due, in a major part, to a circulating macrophage-like cell with active suppressor function.


Assuntos
Carcinoma de Células de Transição/imunologia , Citotoxicidade Imunológica , Macrófagos/imunologia , Linfócitos T Reguladores/imunologia , Neoplasias da Bexiga Urinária/imunologia , Carcinoma de Células de Transição/patologia , Carcinoma de Células de Transição/cirurgia , Divisão Celular , Separação Celular , Seguimentos , Humanos , Imunidade Celular , Teste de Cultura Mista de Linfócitos , Pessoa de Meia-Idade , Monócitos/imunologia , Neoplasias da Bexiga Urinária/patologia , Neoplasias da Bexiga Urinária/cirurgia
13.
Cancer Res ; 36(1): 132-7, 1976 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1082369

RESUMO

One hundred three patients with varying stages of urological cancer (bladder, prostate, kidney) were investigated with regard to the following lymphocyte functions. T-cells were assessed numerically (E rosettes), their blastogenic response to phytohemagglutinin (pHA) was determined, and their cytotoxic potential against heterologous target cells in short-term presence of PHA (e.i., PHA-dependent cellular cytotoxocity) was evaluated. Similarly, B cells were numerically assessed (EA rosettes), and their function was evaluated by antibody-dependent cellular cytotoxicity against antibody-coated deterologous target cells. The data on cancer patients, divided on the basis of extent of disease and prior radiation therapy, were compared to those of normal young and age-matched controls. Our investigations emphasize the importance of the following factors: (a) comparison of data with age-matched controls, since several lymphocyte functions appear to change with age; (b) use of multiple controls to compensate for the inherent variability found in certain tests; (c) minimized contamination by nonlymphoid cells in the purified cell preparation; and (d) the influence of certain treatment regimens (radiation, chemotherapy, etc.) on the results. Radiotherapy significantly depressed T-cell number with a depression of PHA blastogenic responses as well as PHA-dependent cellular cytotoxicity. When all of these conditions were taken into account, the urological cancer patients as a group were found to have a lower proportional value of E rosettes (T-cells) and a reduced PHA blastogenic responsiveness. Certain cancer patients displayed an elevated PHA-dependent cellular cytotoxicity as compared to age-matched controls, which may indicate the presence of activated cells in the presence of tumors. With this identification of a group of cancer patients with markedly depressed E rosette values and PHA responsiveness, it will now be possible to follow them clinically in comparison with a group of cancer patients with normal T-cell functions.


Assuntos
Linfócitos B/imunologia , Linfócitos T/imunologia , Neoplasias Urogenitais/imunologia , Adulto , Idoso , Contagem de Células , Testes Imunológicos de Citotoxicidade , Feminino , Humanos , Hipersensibilidade Tardia , Reação de Imunoaderência , Neoplasias Renais/imunologia , Lectinas/farmacologia , Ativação Linfocitária , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/imunologia , Testes Cutâneos , Neoplasias da Bexiga Urinária/imunologia , Neoplasias Urogenitais/radioterapia
14.
Cancer Res ; 42(6): 2392-7, 1982 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7074617

RESUMO

A serum-free medium, DH-S1, is described which is valuable for the establishment of primary cultures of normal and malignant transitional epithelium (transitional cell carcinoma of the bladder). Growth of epithelial cells in DH-S1 is facilitated but that of fibroblasts is suppressed. Another established human transitional cell carcinoma cell line, 647V, has grown continually in DH-S1 for over 36 passages. Morphological and antigenic studies comparing 647V cells growing in serum-containing and serum-free medium reveal differences which are pronounced at low cell density but which almost disappear at higher densities. A new human transitional cell carcinoma cell line, LA-B1, is described whose initial growth was supported by this serum-free medium.


Assuntos
Neoplasias da Bexiga Urinária/fisiopatologia , Bexiga Urinária/fisiologia , Animais , Sangue , Divisão Celular , Linhagem Celular , Células Cultivadas , Meios de Cultura , Epitélio/fisiologia , Humanos , Cinética , Camundongos
15.
Cancer Res ; 46(3): 1219-23, 1986 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-3080240

RESUMO

An autocrine (noninterleukin 2) growth factor, which we term leukemia derived growth factor (LDGF), has previously been found in the culture supernatant of the human malignant T-lymphoid cell line MOLT-4f. We now show that two other human malignant T-lymphoid cell lines, CCRF-CEM and CCRF-HSB-2 also produce such a factor. All three factors, i.e., the LDGF from MOLT-4f, CCRF-CEM, and CCRF-HSB-2 are similar to each other both in biological activity and in physicochemical characteristics. In addition to their autocrine activity, these LDGFs stimulate the growth of other malignant T-lymphoid cell lines, but they do not stimulate B-lymphoblastoid or myeloid cell lines. The results therefore suggest that these LDGFs are T-cell specific.


Assuntos
Substâncias de Crescimento/biossíntese , Linfoma/metabolismo , Biossíntese Peptídica , Linfócitos T/metabolismo , Antígenos de Diferenciação de Linfócitos T , Antígenos de Neoplasias/análise , Antígenos de Superfície/análise , Linfócitos B/citologia , Linfócitos B/imunologia , Linfócitos B/metabolismo , Ciclo Celular/efeitos dos fármacos , Linhagem Celular , Relação Dose-Resposta a Droga , Humanos , Interleucina-2/farmacologia , Linfoma/patologia , Soroalbumina Bovina/farmacologia , Linfócitos T/citologia , Linfócitos T/imunologia , Fatores de Crescimento Transformadores
16.
Cancer Res ; 37(5): 1468-75, 1977 May.
Artigo em Inglês | MEDLINE | ID: mdl-140004

RESUMO

A rabbit antiserum to first-trimester human fetal tissue had greater reactivity in complement fixation and saturation binding assays with fetal tissues than with both a pool of normal adult lung, liver, and kidney and pools of the individual organs. This anti-fetal membrane reactivity was only partially inhibited by carcinoembryonic antigen. The serum still reacted strongly with human fetal and tumor cells after rendering it specific for plasma membrane components by adsorption to and elution from intact human fetal tissue culture cells. This plasma membrane-specific serum was then used to monitor the purification of the fetal membrane-associated antigens. The fetal antigens copurified with the putative plasma membrane enzymatic markers 5'-nucleotidase and Mg2+-adenosinetriphosphatase through differential and density gradient centrifugation. Insulin-binding activity only partially copurified with the antigenic activity. Little antigenic activity was found in nuclear and mitochondrial fractions. The isolation protocol gives fetal plasma membrane-associated antigens in approximately 50% yield with moderate purification. The sera and isolation procedures described should have general utility for the detection of human oncofetal antigens.


Assuntos
Antígenos , Membrana Celular , Feto/imunologia , Adenosina Trifosfatases/metabolismo , Antígenos/análise , Fracionamento Celular , Membrana Celular/enzimologia , Membrana Celular/imunologia , Membrana Celular/metabolismo , Centrifugação , Feminino , Humanos , Insulina/metabolismo , Nucleotidases/metabolismo , Gravidez , Primeiro Trimestre da Gravidez
17.
J Clin Oncol ; 12(4): 827-34, 1994 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8151325

RESUMO

PURPOSE: To identify risk factors that might predict for systemic fungal infections in marrow transplant recipients within the first 100 days and to assess the efficacy of low-dose amphotericin B used as prophylaxis for candidemia and infection with invasive Aspergillus species in patients at risk. PATIENTS AND METHODS: A retrospective analysis of transplant outcomes for 331 allogeneic marrow recipients transplanted between 1983 and 1989 was performed to identify patients who might be at increased risk of fungal infection. Factors analyzed included disease, remission status, transplant regimen, graft-versus-host disease (GVHD) prophylaxis, duration of neutropenia, and development of GVHD. A trial of low-dose amphotericin (5 to 10 mg/d) begun on day +1 and continuing for 2 to 3 months posttransplant was begun in 1987 to evaluate its utility in reducing systemic mycoses. RESULTS: There were 18 episodes of candidemia and 18 systemic mycoses documented by blood or tissue culture or by biopsy. The initiation of high-dose (0.5 to 1 mg/kg/d) corticosteroids early as a component of GVHD prophylaxis in 1986 was identified as the most important risk factor for fungal infections, with a sixfold increase in infections as compared with the previous GVHD regimen (P < .0001); this was despite a significant decrease in the incidence of grade II to IV GVHD (7% v 43%; P = .0001). Low-dose amphotericin B initiated before the start of high-dose corticosteroid GVHD prophylaxis reduced the incidence of fungal infections from 30% to 9% (P = .01) without renal toxicity. Cyclosporine levels were lower in the patients who received amphotericin, leading to an increase in the rate of GVHD to 19% (P = .02). Controlling for GVHD prophylaxis, prolonged neutropenia (P = .00), and grade II to IV GVHD (P = .01) were also identified as risk factors for fungal infection. CONCLUSION: Amphotericin B can be used in low doses as prophylaxis for fungal infections early in the posttransplant course. However, cyclosporine doses need to be monitored to maintain target levels.


Assuntos
Anfotericina B/uso terapêutico , Transplante de Medula Óssea/efeitos adversos , Micoses/prevenção & controle , Infecções Oportunistas/prevenção & controle , Adolescente , Adulto , Criança , Pré-Escolar , Ciclosporina/efeitos adversos , Feminino , Humanos , Incidência , Lactente , Masculino , Pessoa de Meia-Idade , Micoses/etiologia , Micoses/microbiologia , Infecções Oportunistas/etiologia , Valor Preditivo dos Testes , Estudos Retrospectivos , Fatores de Risco , Análise de Sobrevida , Resultado do Tratamento
18.
J Clin Oncol ; 9(9): 1570-4, 1991 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1875218

RESUMO

The survival of patients with acute leukemia who do not achieve a remission with primary therapy is very poor. High-dose chemoradiotherapy followed by allogeneic bone marrow transplantation (BMT) has been shown to be effective therapy for patients with acute and chronic leukemia. Therefore, we determined the long-term disease-free survival of patients who did not achieve a remission and were then treated with high-dose therapy and bone marrow allografting from matched sibling donors. Twenty-one patients (median age, 28 years) who did not achieve a remission with induction chemotherapy were subsequently treated with allogeneic BMT. After BMT, 90% achieved a complete remission. Six died of complications of the therapy, and six patients relapsed between 27 and 448 days after BMT. Nine patients (43%; median age, 25 years) are alive between 556 and 4,174 days after BMT. The cumulative probability of disease-free survival at 10 years is 43%. This study suggests that allogeneic BMT can be an effective therapy to achieve long-term control of acute leukemia, even in those patients who do not achieve a remission with primary therapy.


Assuntos
Transplante de Medula Óssea , Leucemia Mieloide Aguda/cirurgia , Leucemia-Linfoma Linfoblástico de Células Precursoras/cirurgia , Adolescente , Adulto , Criança , Pré-Escolar , Humanos , Probabilidade , Indução de Remissão , Taxa de Sobrevida , Transplante Homólogo
19.
J Clin Oncol ; 4(10): 1489-92, 1986 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-3531423

RESUMO

During the past 10 years, 86 patients 30 to 54 years of age with hematologic malignancies were prepared with high-dose radiochemotherapy and received histocompatible bone marrow grafts. Thirty-four of these patients are surviving for 4 months to 9 years (median, 26 months) following marrow transplantation and 32 of them are in continuing complete remission (CR). Disease-free survival is 44% for 37 patients who were in first remission of acute leukemia or in the chronic phase of chronic granulocytic leukemia (CGL), 23% for 39 patients whose leukemia had relapsed at least once before transplantation or who had advanced stages of CGL, and 60% for ten patients who had hematologic malignancies other than leukemia. The median age of the surviving 34 patients is 36 years (range, 30 to 43 years). The incidence of moderate to severe acute graft-v-host disease (GVHD) was 48% and of chronic GVHD, 26%. The major causes of failure were interstitial pneumonia in 31 patients (24 of whom had antecedent acute GVHD) and recurrent leukemia in 12 patients (11 of whom had either never entered a CR or had relapsed at least once with acute leukemia or had progressive CGL before transplantation). Our data warrant further prospective studies in patients with hematologic malignancies who are older than 30 years.


Assuntos
Transplante de Medula Óssea , Leucemia/terapia , Análise Atuarial , Adulto , Anemia/terapia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Terapia Combinada , Doença Enxerto-Hospedeiro/prevenção & controle , Humanos , Leucemia/mortalidade , Leucemia/patologia , Pessoa de Meia-Idade , Prognóstico , Irradiação Corporal Total
20.
J Clin Oncol ; 5(11): 1822-6, 1987 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3316515

RESUMO

Twenty patients (age range, 4 to 48 years; median age, 36 years) with de novo or drug-induced myelodysplastic syndromes or myeloproliferative disorders were treated with myeloablative immunosuppressive therapy followed by bone marrow transplantation (BMT). Four preparative regimens were used; three regimens consisted of combined total body irradiation (TBI) and chemotherapy and one of combination chemotherapy only. One patient received marrow from his identical twin brother, whereas the other 19 patients were grafted with marrow from histocompatible siblings. In 19 patients the abnormal clone was at least temporarily ablated, while in one patient the congenital myelodysplasia persisted. Eight patients are alive and well for +108 to +3,359 days post-transplantation. Nine patients died of transplant-related complications (six of interstitial pneumonia, two of gastrointestinal bleeding, and one of fungal sepsis) and three patients died with persisting or recurring disease. One patient with a late recurrence has undergone a second successful bone marrow transplant procedure. Outcome of BMT was not related to French-American-British (FAB) type, marrow fibrosis, cytogenetic abnormalities, or preparation regimen. Marrow transplantation as a means of providing long-term disease-free survival and possible cure should be considered in patients if a suitable donor is available.


Assuntos
Transplante de Medula Óssea , Síndromes Mielodisplásicas/terapia , Transtornos Mieloproliferativos/terapia , Adolescente , Adulto , Criança , Pré-Escolar , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Síndromes Mielodisplásicas/tratamento farmacológico , Síndromes Mielodisplásicas/radioterapia , Transtornos Mieloproliferativos/tratamento farmacológico , Transtornos Mieloproliferativos/radioterapia , Recidiva , Doadores de Tecidos , Irradiação Corporal Total
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA